
Tesofensine 500MCG x 100 Capsules ( For Research Purposes Only)
$175.00
In stock
Description
Tesofensine (CAS: 195875-80-4) – Research Chemical
Molecular Formula: C_17H_23ClN_2O
Molecular Weight: 306.83 g/mol
Synonyms: NS-2330
Purity: ≥99% (HPLC)
Intended Use:
Tesofensine is exclusively for laboratory research purposes. It is not intended for diagnostic, therapeutic, or human consumption. This compound should be handled only by qualified researchers in regulated research environments.
Storage Guidelines:
- Store in a cool, dry place away from moisture and direct sunlight.
- Keep in a secure research facility with proper labeling and handling procedures.
- Follow laboratory protocols for safe storage and disposal.
Legal Disclaimer:
This product has not been evaluated or approved by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. Tesofensine is sold strictly for research purposes in compliance with all applicable regulations. Any misuse or off-label application is strictly prohibited.
Keywords: Tesofensine research, monoamine reuptake inhibitor, neurotransmitter studies, metabolic research compound, laboratory-grade tesofensine, high-purity research chemical, preclinical neurobiology studies.
Related products
Lipo-C / Shred 10mL ( Research Use Only )
- L-Carnitine: 20mg
- L-Arginine: 20mg
- Methionine: 25mg
- Inositol: 50mg
- Choline: 50mg
- B6 (Pyridoxine): 25mg
- B5 (Dexpanthenol): 25mg
- B12 (Methylcobalamin): 1mg
Retatrutide Reta 30mg Lyophilized Powder ( Research Use Only)
CJC-1295 5mg without DAC ( For Research Use Only )
SNAP 8 15mg Cosmetic / Topical lypholized powder
Tesamorelin 5mg Lypholized Powder ( For Research Use Only )
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), slightly modified to extend its half-life. Tesamorelin is utilized in research to study its effects on growth hormone release, offering significant potential for future scientific investigation.
For Research Use Only
Not for Human or Veterinary Use
Reviews
There are no reviews yet.